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Phosphate content determinations established that m aB-crystallin two phosphate groups can be present in vivo in bovine lenses. Comparison of 
tryptic digests of phosphorylated and unphosphorylated aB chains, revealed the location of the two phosphorylation sites in tryptic peptides T2 
and T3. Thermolytic digestion and gas-phase sequencing demonstrated that Ser-19 and Ser-45 are the in vivo phosphorylation sites of bovine aB- 
crystallin. This pattern of phosphorylation differs from the previously reported in vitro obtained results. 
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1. INTRODUCTION 
cu-Crystallin is an abundant protein in the eye lenses of 
most vertebrates. It occurs as large aggregates, compos- 
ed of two types of 20 kDa subunits, crA and cuB, which 
show a sequence homology of 55% [l]. a-Crystallin is 
evolutionarily related with the small HSPs [2], which 
makes it conceivable that these proteins share certain 
functional properties, probably related with stress 
resistance [3]. It has recently been found that aB- 
crystallin is also present in certain non-lenticular 
tissues, notably in heart [4,5], and at increased levels in 
scrapie-infected hamster brains [6] and in astrocytes of 
patients with Alexanders disease [7]. In mammals, both 
a-crystallin and small HSPs can be phosphorylated in 
vivo [8-l 11, which may relate to their biological func- 
tioning. In vivo and in vitro, the sole phosphorylation 
site in CXA is Ser-122 [9,12]. In aB-crystallin, at least 
two different serine residues can be phosphorylated by 
incubation of lenses with [32P]orthophosphate [ 131. We 
identified the in vivo phosphorylation sites of bovine 
QB-crystallin and established a difference between this 
in vivo phosphorylation pattern and previously 
reported in vitro obtained results. 
2. MATERIALS AND METHODS 
2.1. Isolation and characterization of cu-crystallin subunits 
a-Crystallin was isolated from bovine lenses (4-5 years old) by gel 
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permeation chromatography on Ultrogel AcA 34 (LKB), and 
subunits were separated by ion exchange chromatography on CM-52 
[14] or by chromatofocussing on MonoP (Pharmacia) [15]. Purity of 
the peaks was checked by alkaline urea slab gel electrophoresis [16]. 
The different cuB chains were digested with trypsin (Worthington), 
and the resulting peptides were separated by paper electrophoresis 
and chromatography [ 141. Peptides were located with fluorescamine 
and eluted with 5% acetic acid for amino acid analysis. Preparative 
isolation of the large ‘core’ peptide T3 for phosphate content deter- 
mination was performed by gel filtration over Sephadex G50 super- 
fine, where T3 coelutes with T16 [14]. Pure T3, for subdigestion and 
sequence analysis, was obtained by RP-HPLC of tryptic digests, us- 
ing a 300-RP-8 column (Merck), eluting at a flow rate of 0.8 ml/min 
with a gradient of 0.1% TFA versus acetonitrile (Rathburn) (0 to 
100% in 100 min) containing 0.1% TFA (Pierce). T3 was further 
digested with thermolysin and the resulting peptides were separated 
by RP-HPLC, using an RP-18 column (Merck) and a gradient of 
acetonitrile as indicated in fig.2. 
Sequence determinations to identify the phosphorylated serine 
residues, were performed on an Applied Biosystems model 470A gas- 
phase sequencer equipped with an on-line PTH amino acid analysis 
system. The almost quantitative conversion of phosphoserine 
residues into the PTH-DTT-dehydroalanine adduct during gas phase 
sequencing [17] was used for positive identification of the exact posi- 
tion of the phosphorylated serine residues. 
2.2. Miscellaneous methook 
Cyanogen bromide cleavage was carried out according to standard 
procedures. The resulting fragments were separated by gel permea- 
tion chromatography of Sephadex G50 superfine [14]. The phosphate 
contents of proteins, CNBr-fragments and peptides were determined 
according to the procedure of Fiske-SubbaRow, modified by 
Broeckhuyse [18]. Amino acid analyses after hydrolysis in 6 N HCI 
were carried out on an LKB Alpha Plus amino acid analyser. 
3. RESULTS AND DISCUSSION 
The in vivo occurrence in bovine lenses of mono- 
phosphorylated cuB-crystallin (aB[p] or CYBI, according 
to older nomenclature) had already been established by 
phosphate content determinations [8,9]. In the latter 
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study in vitro phosphorylation of bovine lens homo- 
genates also revealed a minor, I apparently double 
phosphorylated aB chain (aB[2p]). A putative c.uB[2p] 
protein can actually be observed in 4-5-year-old bovine 
lenses, corresponding with the CYBO chain reported by 
Van Kleef et al. [19). We isolated this protein by 
chromatofocussing, and found indeed approximately 2 
mol phosphate/m01 polypeptide (table 1). 
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The aB chain can thus be phosphorylated in vivo at 
two different sites, which we set out to identify by com- 
parative peptide mapping of cuB, cuB[p] and aB[2p] 
(fig. 1A). The only difference between the peptide maps 
of cuB and crB[2p] is the anodal shift of peptide T2 in 
nB[2p], in agreement with a change in charge induced 
by phosphorylation of a serine residue. Indeed, gas 
phase sequencing of T2 of cuB[2p] revealed the sequence 
Arg-Pro-Phe-Phe-Pro-Phe-His-Ser-Pro-Ser-Arg and 
demonstrated the presence of aphosphoserine at posi- 
tion 19 (underlined). In aB[p], T2 is present in both 
charge forms, indicating that the single phosphate 
moiety in cwB[p] can be attached at different serine 
residues. 
ELECTROPHORESIS 
Fig. 1. (A) Peptide map of tryptic digest of bovine aB-crystallin. All 
peptides were identified by amino acid analysis. Numbers indicate the 
order of the tryptic peptides in the bovine crB chain [14]. 2A 
corresponds with unphosphorylated T2 and is present in aB and 
cllB[p], whereas 2B corresponds with the phosphorylated form of T2 
and is present in c~B[p] and (~B[2p]. (B) Part of the elution profiles 
by RP-HPLC of digests from cuB (- -), aB[p] (-) and cuB[Zp] 
(---). 3A corresponds with unphosphorylated T3, 3B with the 
phosphorylated form of T3. 
The second phosphorylation site might be present in 
T3, which is the only peptide lacking on the peptide 
maps, owing to its insolubility in the electrophoresis 
buffer. Phosphate content determinations revealed that 
the phosphate moiety in (YB[P] is exclusively present in 
the N-terminal CNBr fragment, comprising residues 
l-68, whereas the mixture T3/T16, isolated by gel’ 
filtration, contains approximately 0.7 mol P/mol T3 
(table 1). Combining these results it is clear that most 
of T3 is indeed present in a phosphorylated form in 
aB[p]. T3 could not be isolated from aB[2p] in suffi- 
cient amounts for phosphate determinations. 
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Because T3 contains 5 serine residues, further iden- 
tification of the phosphorylation site was necessary. 
We therefore isolated this peptide from total tryptic 
digests of the three cuB chains by RP-HPLC (fig. 1B). A 
clear difference in elution time exists between T3 of cuB 
(peak A) and of cuB[2p] (peak B), whereas T3 of aB[p] 
contains both peaks A and B. This suggests that peak 
Table 1 
15 20 25 30 35 
time (mln) 
Phosphate content of cyB-crystallin subunits, CNBr fragments and 
tryptic peptide mixture T3/T16 
c 30. r(o l 50 
LFDQFFGEHLLESDLFPASTSLSPFYLRPPSFLRPPsFLR 
Phosphate content _ .2 
+Thl-_*.-TW+ -Th3& 4ThW Th5 tTh6+ 
4Th2’-_, -Th3’ ---_*4-Th4-5+ 
v Th3-4-5 -p, 
t-- Th3’-4-5 -__, 
@B 0.04 
CWPI 1.06 
aB ]2~1 2.13 
CNBr I cuB[p] 0.99 
CNBr II (~B[pl 0.03 
T3/T16 cuB[p] 0.61 
The amount of protein or fragments used for phosphate 
measurements was determined by amino acid analysis. Values are 
presented as the molar ratio of phosphate to protein subunit or CNBr 
fragment. In the case of T3/T16, phosphate content is given in mol 
phosphate/m01 T3. presence of phosphoserine (a). 
Fig.2. Elution profiles of thermolytic peptides from the 
unphosphorylated (A) and phosphorylated (B) form of tryptic 
peptide T3, and its amino acid sequence (C) according to Van der 
Ouderaa et al. [14]. Thermolytic peptides were fractionated by RP- 
HPLC and identified by amino acid analysis. Peptides Th3-4-5 and 
Th3 ’ -4-5, instead of Th3, 3 ’ , 4, 4-5 and 5, were only obtained from 
phosphorylated T3, indicating hindrance of cleavage due to the 
!lme(mln) 
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A represents the unphosphorylated form of T3, and 
peak B the phosphorylated T3. Both forms of T3 were 
further digested with thermolysin and the resulting pep- 
tides isolated by RP-HPLC on an RP-18 column 
(fig.2). The differences in elution profiles can be at- 
tributed to incomplete cleavage of T3 from peak B at 
residues Leu-44 and Phe-47. The presence of P-Ser is 
indeed known to hinder the enzymatic cleavage of adja- 
cent sites [9]. Since Thl, Th2 and Th6 from peaks A 
and B have identical retention times, the phosphoryla- 
tion site obviously must be located in the large peptides 
Th3-4-5 and Th3 ’ -4-5. Gas phase sequencing of these 
peptides from the aB[p] chain revealed unambiguously 
a phosphorylated serine residue at position 45 in both 
cases (fig.2). aB-Crystallin can thus be phosphorylated 
at two sites in vivo, namely at Ser-19 and at Ser-45. 
aB[2p] is completely phosphorylated at both sites, 
whereas cuB[p] is a mixture of aB[p45] and aB[pl9], 
with Ser-45 being the major phosphorylated residue in 
this subunit. 
In contrast to cuA-crystallin, where the in vivo 
phosphorylation site is identical to the major in vitro 
one [9,12], a difference exists between the in vivo and 
in vitro phosphorylation sites of cuB-crystallin. Chiesa 
et al. [13] identified two phosphorylation sites in (YB 
after lens incubation in medium containing [32P]or- 
thophosphate: a major site at Ser-59 and a minor site 
at Ser-43 and/or Ser-45. Upon in vitro incubations of 
aB-crystallin in the presence of CAMP-dependent pro- 
tein kinase, we also detected major labeling of tryptic 
peptide T4, comprising Ser-59 (Voorter, C.E.M. and 
De Jong, W.W., unpublished results). However, in the 
native aB[p] chain, no phosphorylation of Ser-59 could 
be detected. Differences between in vivo and in vitro 
sites of phosphorylation have also been demonstrated 
in other proteins [20,21]. 
Interestingly, immunoblot analysis of mouse and 
bovine heart extracts revealed the presence of a more 
acidic minor charge form of cuB (data not shown), com- 
parable with cuB[p] in the lens. Strikingly enough, this 
form is lacking in chicken heart, like in chicken lens [9]. 
The functional implication of the phosphorylation of 
a-crystallin, if any, is still completely unclear. The fact 
that dephosphorylation of cy-crystallin can occur in 
bovine lens extracts, favours the notion that the 
phosphorylation of cu-crystallin is a metabolically con- 
trolled reversible process relating to its biological func- 
tion [22,23]. It should, however, be noted that 
phosphorylation of a-crystallin is by no means a 
universal characteristic among vertebrates [9]. 
Acknowledgement: This work was supported by the Netherlands 
Organization for Scientific Research (NWO). 
REFERENCES 
[l] Bloemendal, H. (ed.) (1981) Molecular and Cellular Biology of 
the Eye Lens, Wiley, New York. 
[2] Ingolia, T.D. and Craig, E.A. (1982) Proc. Natl. Acad. Sci. 
USA 19, 2360-2364. 
[3] De Jong, W.W., Hendriks, W., Mulders, J.W.M. and 
Bloemendal, H. (1989) Trends Biochem. Sci. 14, 365-368. 
[4] Bhat, S.P. and Naginemi, C.N. (1989) Biochem. Biophys. Res. 
Commun. 158, 319-325. 
[S] Dubin, R.A, Wawrousek, E.F. and Piatigorsky, J. (1989) Mol. 
Cell. Biol. 9, 1083-1091. 
[6] Duguid, J.R., Rohwer, R.G. and Seed, B. (1988) Proc. Natl. 
Acad. Sci. USA 85, 5738-5742. 
[7] Iwaki, T., Kume-Iwaki, A., Liem, R.K.H. and Goldman, J.E. 
(1989) Cell 57, 71-78. 
[8] Spector, A., Chiesa, R., Sredy, J. and Garner, W. (1985) Proc. 
Natl. Acad. Sci. USA 82, 4712-4716. 
[9] Voorter, C.E.M., Mulders, J.W.M., Bloemendal, H. and De 
Jong, W.W. (1986) Eur. J. Biochem. 160, 203-210. 
[lo] Welch, W.J. (1985) J. Biol. Chem. 260, 3058-3062. 
[ll] Arrigo, A.-P. and Welch, W.J. (1987) J. Biol. Chem. 262, 
15359-15369. 
[12] Chiesa, R., Gawinowicz-Kolks, M.A., Kleiman, N.J. and 
Spector, A. (1987) Curr. Eye Res. 6, 539-543. 
[13] Chiesa, R., Gawinowicz-Kolks, M.A., Kleiman, N.J. and 
Spector, A. (1987) Biochem. Biophys. Res. Commun. 144, 
1340-1347. 
[14] Van der Ouderaa, F.J., De Jong, W.W., Hilderink, A. and 
Bloemendal, H. (1974) Eur. J. Biochem. 49, 157-168. 
[15] Van den Oetelaar, P.J.M., Bezemer, R. and Hoenders, H.J. 
(1987) J. Chromatogr. 398, 323-326. 
[16] Voorter, C.E.M., De Haard-Hoekman, W.A., Van den 
Oetelaar, P.J.M., Bloemendal, H. and De Jong, W.W. (1988) 
J. Biol. Chem. 263, 19020-19023. 
[17] Meyer, H.E., Hoffmann-Posorske, E., Kuhn, C.C. and 
Heilmeyer, L.M.G. jr. (1988) in: Modern Methods in Protein 
Chemistry 3 (Tschesche, H. ed.) pp. 185-212, Walter de 
Gruyter, Berlin. 
[18] Broeckhuyse, R.M. (1968) Biochim. Biophys. Acta 152, 
307-315. 
[19] van Kleef, F.S.M., Willems-Thijssen, W. and Hoenders, H.J. 
(1976) Eur. J. Biochem. 66, 477-483. 
[20] White, M.F., Takayama, S. and Kahn, C.R. (1985) J. Biol. 
Chem. 260, 9470-9478. 
[21] Murthy, A.S.N., Bramblett, G.T. and Flavin, M. (1985) J. Biol. 
Chem. 260, 4364-4370. 
[22] Chiesa, R. and Spector, A. (1989) Invest. Ophthalmol. Vis. Sci. 
30 (Suppl.), 484. 
[23] Radlick, L.W. and Koretz, J.F. (1989) Invest. Ophthalmol. Vis. 
Sci. 30 (Suppl.), 193. 
52 
